Cue Biopharma, Inc.CUENASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank30
Studio
Year-over-Year Change

Return on equity

Latest
-100.64%
Near historical average
Percentile
P30
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-94.49%
Historical baseline
PeriodValueYoY Change
2025-100.64%+56.7%
2024-232.44%-69.9%
2023-136.80%-69.5%
2022-80.71%-19.7%
2021-67.43%-18.8%
2020-56.75%+15.6%
2019-67.23%+41.4%
2018-114.74%-204.3%
2017-37.71%+25.3%
2016-50.47%-